Condition | MSC source | Isolation method | Mechanism | Main outcome | Ref |
---|---|---|---|---|---|
MI | Cardiac MSC | Precipitation at 4 °C with 5× polyethylene glycol 4000 | Transferring miRs | Promoting cardiac angiogenesis and activating cardiomyocyte proliferation (animal study) | [88] |
MI | BM-MSC | ExoQuick Exosome Precipitation Solution | Delivering miR-221 and miR-19a | Higher protective effects in cardiomyocytes promoted the growth of cardiomyocytes and prevented cell apoptosis (animal study) | |
MI | BM-MSC | Ultracentrifugation (110,000×g) | Delivering miR-210 that decreases the expression of ephrin-A3 | Promoted angiogenesis and cardiac function (animal study) | [91] |
Myocardial IRI | HuES9.E1-derived MSC | Chromatography columns | Stimulating anti-apoptotic pathways and also inhibiting pro-apoptotic pathways | Enhanced bioenergetics and pro-survival signaling of cardiac cells (animal study) | [92] |
MI | BM-MSC | ExoQuick-TC | n.a | Inducing neovascularization and suppressing inflammatory response (animal study) | [93] |
MI | BM-MSC | Ultracentrifugation (200,000×g) | Delivering MiR-125b-5p | Inhibited apoptosis of cardiomyocyte through inhibition of pro-apoptotic genes p53 and BCL2-antagonist/killer 1 (BAK1) (animal study) | [94] |
Autoimmune hepatitis | BM-MSC | Ultracentrifugation (100,000×g) | Delivering exosomal miR-223 | Downregulating various inflammatory genes and proteins and inhibition of hepatocyte death (animal study) | [95] |
Hepatic oxidant injury | UC-MSC | Ultracentrifugation (100,000×g) | Delivering glutathione peroxidase 1 (GPX1) | Suppressed oxidative stress and apoptosis on CCl4-and H2O2-induced hepatic damage (animal study) | [96] |
LF | HuES9.E1-derived MSC | High-performance liquid chromatography (HPLC) | Increasing the expression of cyclin D1 and PCNA as proliferative proteins and enhancing expression of Bcl-xL as an anti-apoptotic factor | Promoting hepatocyte proliferation and inhibiting hepatocyte apoptosis (animal study) | [97] |
Liver fibrosis | BM-MSC | Ultracentrifugation (100,000×g) | Lowering the plasma level of alanine aminotransferase and modulating expression level of inflammatory cytokines and regulatory T cells | Inducing hepatoprotective and anti-inflammatory effects (animal study) | [98] |
LF | ESC-MSC | Ultracentrifugation (100,000×g) | n.a | Enhanced anti-apoptosis, anti-fibrosis, and regenerative capacity (animal study) | [99] |
LF | BM-MSC | Ultracentrifugation (100,000×g) | Delivering Y-RNA-1 | Modulated inflammatory response and by inducing multiple anti-apoptotic genes (animal study) | [100] |
AD | WJ-MSC | Ultracentrifugation (100,000×g) | Delivering catalase | Decreasing neuronal oxidative stress and synapse damage (animal study) | [101] |
Brain stroke | BM-MSC | Ultracentrifugation (100,000×g) | Transferring miR-133b to neighboring astrocytes and neuron cells | Increased functional regeneration (animal study) | [102] |
SCI | BM-MSC | n.a | Enhanced neuro-vascularization and weaken neuronal apoptosis, as well as prevent inflammation and inhibit the neurotoxic of A1 astrocytes | Boosted SCI functional recovery (animal study) | [103] |
SNI | UC-MSCs | Ultracentrifugation | Promoted the generation of axons and Schwann cells, minimized muscular atrophy, and induced anti-inflammatory reactions | Improved functional recovery and peripheral nerve regeneration (animal study) | [104] |
SNI | Gingiva MSC | ExoQuick Exosome Precipitation Solution (SBI Systems Biosciences) | Expression of phenotype-related genes, c-Jun, Notch1, GFAP, Sox2 and the stimulation of JNK pathways | Regeneration of peripheral nerve (animal study) | [105] |
MS | AT-MSC | Ultracentrifugation (100,000×g) | Reducing the number of Iba-1-positive microglial cells and also the plasma levels of inflammatory cytokines | Modulated microglial activity and improved immunomodulatory activities (animal study) | [88] |
AKI | UC-MSCs | Ultracentrifugation (100,000×g) | Transferring hepatocyte growth factor (HGF) mRNA | Improved dedifferentiation and proliferation of damaged cells (animal study) | [89] |
Kidney IRI | n.a | n.a | Delivering miR-22 for mTOR/HIF feedback interaction pathway and suppressing (PDCD4)/NFKB pathways | Stimulating kidney protection by inducing anti-inflammatory responses and reducing epithelial cell damage (animal study) | [106] |
Kidney IRI | WJ-MSC | Ultracentrifugation (100,000×g) | Reduced kidney cell apoptosis and boosted anti-inflammatory responses | Downregulated CX3CL1 expression and improved kidney function (animal study) | [107] |
AKI | UC-MSCs | Ultracentrifugation (100,000×g) | Activation of the ERK 1/2 pathway and inhibition of the p38MAPK pathway | Suppressing oxidative stress, inducing cell growth, and reducing kidney cell apoptosis (animal study) | [108] |
CKD | Urinary MSC | Ultracentrifugation (100,000×g) | Delivering effective growth factors | Inhibited cell apoptosis and increased vascular regeneration (animal study) | [109] |
Kidney artery stenosis | AT-MSC | n.a | Delivering anti-inflammatory cytokine interleukin (IL) 10 | Attenuated kidney inflammation and fibrosis, increased kidney blood supply, and suppressed glomerular filtration (animal study) | [110] |
Kidney fibrosis | BM-MSC | ExoQuick Exosome Precipitation Solution | Delivering exogenous microRNA let7c | Suppression of kidney inflammation (animal study) | [111] |
ALI | UCB-MSC | Ultracentrifugation (100,000×g) | Delivering VEGF | Restored impaired alveoli function, angiogenic effects, and anti-inflammatory responses and minimized cell apoptosis (animal study) | [112] |
ALI | AT-MSC | Ultracentrifugation | Delivering miRNA | Attenuating ALI damage and macrophages polarization (animal study) | [113] |
Lung IRI | BM-MSCs | n.a | Transferring miR-21-5p | Inhibited lung edema and improved the function of wound healing (animal study) | [114] |
ALI | BM-MSC | Ultracentrifugation | Transferring KGF | Promoted immunomodulatory effects and increased intracellular ATP levels of alveolar epithelial type 2 cell (animal study) | [115] |
ALI | BM-MSC | Ultracentrifugation (100,000×g) | Transferring mitochondrial | Inhibited the production of inflammatory cytokines and enhanced phenotype 2 of alveolar macrophages (animal study) | [116] |
PAH | BM-MSC | Ultracentrifugation (100,000×g) | Alleviated pressure, inhibited right ventricle hypertrophy, and restored pulmonary function | Improved pulmonary artery hypertension (animal study) | [117] |